Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWFCW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48,749.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes on September 15, 2025, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, which specializes in supplying medications and medical products to federal healthcare systems. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical items supporting Department of Defense medical facilities worldwide.
Stelara is a biologic immunosuppressant medication used to treat various autoimmune conditions, and this delivery order reflects the routine pharmaceutical replenishment needs of the military health system. DMS Pharmaceutical Group has demonstrated consistent capability in fulfilling pharmaceutical supply contracts for DLA, with a robust portfolio covering prescription medications, biologics, and medical consumables. As a certified woman-owned small business registered in SAM.gov since 2001, the contractor has successfully leveraged its status to compete in federal procurement markets while maintaining a significant role in the defense pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FWFCW?
SPE2DB25FWFCW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FWFCW worth?
The government has obligated $48,750 on SPE2DB25FWFCW.
Is contract SPE2DB25FWFCW an order under another contract?
Yes. SPE2DB25FWFCW is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFCW competed?
The extent of competition for SPE2DB25FWFCW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award